Touho H, Karasawa J, Ohnishi H, Yamada K, Ito M, Kinoshita A
Department of Neurosurgery, Osaka Neurological Institute, Japan.
Surg Neurol. 1994 Aug;42(2):148-56. doi: 10.1016/0090-3019(94)90376-x.
Spinal arteriovenous malformations (spinal AVMs) are now treated using microcatheters and various embolic materials. Interventional techniques of this type are thought to be the first choice for treatment of spinal AVMs. In this study, we used the Tracker vascular access system and MAGIC catheter for intravascular treatment of spinal AVMs in order to avoid proximal occlusion. Notably, serial provocation tests using xylocaine (20 mg in bolus) and intermittent intravascular pressure monitoring in the anterior spinal artery were conducted during embolizations of five intramedullary AVMs. We used 150-350 microns polyvinyl alcohol particles (Ivalon) and/or polyvinyl alcohol (PVA) solutions as embolic materials for occlusion of these AVMs. Vital signs and neurologic functions were carefully monitored during and after the procedure. We were able totally to obliterate the nidus or markedly to reduce its size while preserving the anterior spinal artery in each of the patients. The xylocaine test was conducted an average of 2.6 times (2-4 times) during embolization. For the two patients who were treated with Ivalon and PVA solutions, the final provocation test became positive, and the embolization procedure was terminated. On the other hand, the remaining patients had a positive result on first xylocaine test and were treated with Ivalon alone. At the same time, intravascular pressure monitoring was performed via the microcatheter, which was located in the anterior spinal artery. The value of the intravascular systolic pressure prior to embolization was 71.6 +/- 14.1 mm Hg and it gradually increased during the procedure, and reached 99.6 +/- 12.6 mm Hg (90% of the systemic systolic blood pressure) by the conclusion of embolization. Serial xylocaine tests and intravascular pressure monitoring may be useful for the treatment of spinal AVMs fed mainly by the anterior spinal artery, and embolization with liquid embolic material should be terminated when the provocation test becomes positive and intravascular pressure increased to 90% of the systemic blood pressure.
脊髓动静脉畸形(脊髓AVM)目前采用微导管和各种栓塞材料进行治疗。这类介入技术被认为是治疗脊髓AVM的首选方法。在本研究中,我们使用Tracker血管通路系统和MAGIC导管对脊髓AVM进行血管内治疗,以避免近端闭塞。值得注意的是,在对5例髓内AVM进行栓塞治疗期间,使用利多卡因(20mg推注)进行了系列激发试验,并在前脊髓动脉进行了间歇性血管内压力监测。我们使用150 - 350微米的聚乙烯醇颗粒(Ivalon)和/或聚乙烯醇(PVA)溶液作为栓塞材料来闭塞这些AVM。在手术过程中和术后仔细监测生命体征和神经功能。我们能够在保留每位患者前脊髓动脉的同时,完全闭塞畸形灶或显著减小其大小。在栓塞过程中,利多卡因试验平均进行2.6次(2 - 4次)。对于接受Ivalon和PVA溶液治疗的2例患者,最终激发试验呈阳性,栓塞手术终止。另一方面,其余患者首次利多卡因试验结果为阳性,仅接受Ivalon治疗。同时,通过位于前脊髓动脉的微导管进行血管内压力监测。栓塞前血管内收缩压值为71.6±14.1mmHg,在手术过程中逐渐升高,栓塞结束时达到99.6±12.6mmHg(全身收缩压的90%)。系列利多卡因试验和血管内压力监测可能有助于治疗主要由前脊髓动脉供血的脊髓AVM,当激发试验呈阳性且血管内压力升高至全身血压的90%时,应终止使用液体栓塞材料进行栓塞。